Abbott India Limited

Abbott India Limited (ABBOTINDIA) is a mid-cap Healthcare company valued at ₹55,577 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Abbott India Limited last traded at ₹26,010, modestly down 1.08% on the day.

Recent developments

On 2026-08-13, Abbott India reported its Q1 FY27 results, showing revenue of ₹1,813 crore and PAT of ₹428 crore, with key highlights indicating continued performance. On 2026-08-12, the company was mentioned in a list of results released on Aug 12, but no specific details were provided.

Financial performance

The company's business is improving, with annual revenue rising 8.1% and annual net profit growing 9.8%. The latest quarter saw revenue increase 4.4% compared to the same quarter a year earlier, while net profit rose 17.2%, driven by stronger profitability despite modest revenue growth.

Valuation multiples

The stock trades at 35.6 times earnings, broadly in line with the Healthcare median of 32.0, 11.45 times book value. It yields 2.6%.

Things to watch

The stock is 15.2% below its 52-week high, which may indicate a pullback from recent price levels. Promoter holding remains at 74.99%, but domestic institutional holding decreased by 0.15 percentage points in the quarter, suggesting some short-term selling pressure.

Where it stands

Abbott India has shown consistent revenue and profit growth over the past five years, with recent quarterly results reflecting continued profitability. The most significant movement was in net profit, which rose 17.2% in the latest quarter. The stock is currently trading below its 52-week high, but the company remains profitable with strong returns on equity and capital employed.

Summarised by DocStoX's model on 2026-10-10 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.